What is BioCircuit Technologies?
BioCircuit Technologies is a medical technology innovator dedicated to transforming the landscape of tissue repair and neuromodulation. The company is best known for its flagship product, Nerve Tape, which represents a significant advancement in surgical instrumentation as the first FDA-cleared sutureless device for repairing transected nerves. By focusing on reducing tissue trauma and improving surgical efficiency, the company addresses critical pain points for clinicians in plastic and reconstructive surgery.
The firm operates at the intersection of biotechnology and advanced engineering, providing tools that streamline complex procedures. Its market position is defined by a commitment to clinical excellence and the development of proprietary platforms that facilitate better patient outcomes in nerve injury management.
How much funding has BioCircuit Technologies raised?
BioCircuit Technologies has raised a total of $9M across 1 funding round:
Angel/Seed
$9M
Angel/Seed (2022): $9M with participation from GRA Venture Fund and Masters Capital Management
Key Investors in BioCircuit Technologies
GRA Venture Fund
A public-private venture capital fund that invests in research-driven startup companies, focusing on elite enterprises emerging from science and technology sectors.
Masters Capital Management
An Atlanta-based SEC registered investment adviser that specializes in managing US equities and listed equity options to deliver long-term absolute returns.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for BioCircuit Technologies?
Looking ahead, BioCircuit Technologies is expected to leverage this major strategic investment to broaden its clinical reach and refine its product pipeline. The company's roadmap likely includes expanding the indications for its Nerve Tape technology and investing in further research to solidify its leadership in the neuromodulation sector. As the firm scales, it will likely focus on strategic partnerships with healthcare systems to integrate its devices into standard surgical protocols, thereby driving long-term value for stakeholders and improving the standard of care for patients suffering from nerve-related trauma.
See full BioCircuit Technologies company page
